Robotic device appears to be more precise than
conventional catheter ablation devices for a trial
fibrillation
A remotely-controlled catheter device guided by magnetic
fields provides a safe and practical method for
delivering radio frequency ablation treatment in the
hearts of patients with a trial fibrillation, according
to a new study in the April 4, 2006, issue of the
Journal of the American College of Cardiology.
"Based on our experience with remote navigation and
ablation technology, a new era in interventional
electrophysiology is beginning as magnetic, very soft
catheters can be navigated in the heart more precisely
and safely than manual catheters without risk of major
complications, even in less experienced centers," said
Carlo Pappone, M.D., Ph.D. from the Department of
Electrophysiology, San Raffaele University Hospital in
Milan, Italy.
Atrial fibrillation is an abnormal heart rhythm in which
the upper chambers of the heart flutter, and do not pump
blood normally. If the condition cannot be managed with
medications, some patients are treated with radio
frequency ablation. The technique uses a high energy
pulse to destroy a small area of heart muscle cells, in
order to prevent them from conducting nerve signals that
trigger fibrillation.
Typically the radio frequency pulse is emitted by from
the tip of a catheter threaded through blood vessels
into the heart until it is positioned next to the target
area. Conventional catheters are somewhat stiff, so they
can be pushed and pulled through blood vessels, and
their tips can be curled and pointed by an operator
standing by the patient. The device tested in this trial
uses a very soft, limp tip that has a magnet on the end.
Rather than manually pointing the catheter tip, the
operator of this device uses a computer to control a
magnetic field that robotically moves the catheter tip.
The principle is the same as a compass needle pointing
to magnetic north; allowing this device to steer the
magnetic catheter in three dimensions to a target
visualized on 3-D scans of the patient's heart.
"Catheter ablation for atrial fibrillation is now an
important treatment for this common disorder, but the
current strategy of manual catheter manipulation is
highly operator-dependent, with a long and variable
learning curve and a great potential for both inefficacy
and complications in inexperienced hands. Robotic
navigation may increase the ability of inexperienced
operators to perform this procedure easily and safely,
as it is most dependent on a well-trained team rather
than on a single operator," Dr. Pappone said.
Since catheter procedures of this type require frequent
use of X-rays to track the location of the target and
the catheter tip, another advantage of remote navigation
is that the operator can work from a shielded control
room, rather than having to stand next to the patient
for several hours while wearing protective lead aprons.
This first trial of the robotic magnetic navigation
system in patients with atrial fibrillation involved 40
participants whose conditions were not adequately
controlled by medication. After encountering some
difficulties in the first three patients, the
researchers said the remaining procedures went smoothly.
In all, the catheter tip was successfully guided by
magnetic navigation to the target and radio frequency
ablation was applied in 38 of the 40 study participants.
There were no reported complications during the
procedures.
"Based on our results, we believe that incorporation of
remote navigation and ablation in the electrophysiology
laboratory may represent a true revolution regardless of
age and experience of the operators leading to a seismic
change in electrophysiologic paradigms for many
laboratories worldwide. People always have had a
love/hate relationship with robots, but this
psychological barrier must be overcome. After performing
more than 10,000 procedures with manually deflectable
catheters, I have become enthusiastic for this emerging
field," Dr. Pappone said.
E. Kevin Heist, M.D., Ph.D. from Massachusetts General
Hospital in Boston, who was not connected with this
study, said even though catheter ablation is more
successful than medical treatment for atrial
fibrillation, the conventional procedure can be long and
difficult.
"Catheter ablation as currently practiced with hand
held, manually deflected catheters is a long procedure,
typically 3 to 5 hours, has a long learning curve, and
has a significant risk of procedural complications and
of recurrent atrial fibrillation after the procedure.
Robotic catheter navigation with a magnet-tipped
catheter directed by large, computer directed magnets
can provide more precise catheter control as compared to
manual catheter manipulation. This has the potential, as
yet unproven, to shorten the procedure, reduce the
length of the learning curve, and perhaps to improve the
outcomes of the procedure and reduce complications," Dr.
Heist said.
Dr. Heist said future trials will be needed to directly
compare robotic navigation to conventional manually
operated catheters in regard to procedural safety and
efficacy.
Mitchell N. Faddis M.D., Ph.D. from the Washington
University School of Medicine in St. Louis, Missouri,
who was not involved with this study, helped develop the
remote magnetic navigation system the researchers used.
"The work of Pappone et al. is extremely exciting to me
as the culmination of this work, and to the cardiology
community in general as a potential important technical
advance in the treatment of atrial fibrillation," Dr.
Faddis said.
Dr. Faddis said this new system should be easier to
master, as well as being more precise, than conventional
catheter ablation.
"Because of computer control, the efficiency of the
procedure may improve. By the end of the 40 patient
cohort of Pappone et al., procedures were routinely
performed in less than an hour. This will likely have an
important impact on the complication rate for the
procedure which is likely affected by procedure
duration," he said.